Xenon Pharmaceuticals Inc (XENE)
40.62
+0.52
(+1.30%)
USD |
NASDAQ |
Apr 26, 14:17
Xenon Pharmaceuticals Price to Book Value: 3.302 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.260 |
| April 24, 2024 | 3.211 |
| April 23, 2024 | 3.340 |
| April 22, 2024 | 3.252 |
| April 19, 2024 | 3.242 |
| April 18, 2024 | 3.277 |
| April 17, 2024 | 3.384 |
| April 16, 2024 | 3.373 |
| April 15, 2024 | 3.358 |
| April 12, 2024 | 3.357 |
| April 11, 2024 | 3.493 |
| April 10, 2024 | 3.449 |
| April 09, 2024 | 3.498 |
| April 08, 2024 | 3.465 |
| April 05, 2024 | 3.435 |
| April 04, 2024 | 3.431 |
| April 03, 2024 | 3.357 |
| April 02, 2024 | 3.371 |
| April 01, 2024 | 3.426 |
| March 28, 2024 | 3.500 |
| March 27, 2024 | 3.496 |
| March 26, 2024 | 3.468 |
| March 25, 2024 | 3.471 |
| March 22, 2024 | 3.577 |
| March 21, 2024 | 3.532 |
| Date | Value |
|---|---|
| March 20, 2024 | 3.560 |
| March 19, 2024 | 3.605 |
| March 18, 2024 | 3.487 |
| March 15, 2024 | 3.574 |
| March 14, 2024 | 3.55 |
| March 13, 2024 | 3.665 |
| March 12, 2024 | 3.597 |
| March 11, 2024 | 3.607 |
| March 08, 2024 | 3.759 |
| March 07, 2024 | 3.752 |
| March 06, 2024 | 3.736 |
| March 05, 2024 | 3.739 |
| March 04, 2024 | 3.735 |
| March 01, 2024 | 3.808 |
| February 29, 2024 | 3.837 |
| February 28, 2024 | 3.889 |
| February 27, 2024 | 4.034 |
| February 26, 2024 | 3.994 |
| February 23, 2024 | 4.017 |
| February 22, 2024 | 4.000 |
| February 21, 2024 | 3.966 |
| February 20, 2024 | 3.933 |
| February 16, 2024 | 3.973 |
| February 15, 2024 | 3.955 |
| February 14, 2024 | 3.939 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.905
Minimum
Oct 28 2020
7.544
Maximum
Nov 05 2021
3.431
Average
3.153
Median
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4244 |
| Aurinia Pharmaceuticals Inc | 1.886 |
| Edesa Biotech Inc | 2.425 |
| Lexaria Bioscience Corp | 4.505 |
| ESSA Pharma Inc | 1.902 |
Price to Book Value Related Metrics
| PS Ratio | 206.29 |
| PEG Ratio | -1.061 |
| Price | 40.62 |
| Earnings Yield | -6.70% |
| Market Cap | 3.064B |
| PEGY Ratio | -1.061 |